Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Clinical Cancer Research|2016Cited by 42
Mécanismes de sensibilité/résistance des cellules tumorales aux inhibiteurs de réparation de l'ADN Dbait.Wael Jdey|theses.fr (ABES)|2016Cited by 0
Abstract 1110: AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancer AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancerM. Dutreix, Graham Dixon, Wael Jdey et al.|Cancer Research|2017Cited by 0
Data from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Andreï Zinovyev et al.|Unknown|2023Cited by 0
Supplementary figure S2 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0